Enanta Pharmaceuticals
ENTA
#7451
Rank
โ‚น37.85 B
Marketcap
โ‚น1,312
Share price
3.62%
Change (1 day)
93.60%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2025 (TTM): -โ‚น7.34 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น64.8 Million. In 2024 the company made an earning of -โ‚น8.72 Billion, an increase over its 2023 earnings that were of -โ‚น11.45 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น7.34 Billion-15.84%
2024 -โ‚น8.72 Billion-23.87%
2023 -โ‚น11.45 Billion4.39%
2022 -โ‚น10.97 Billion-4.4%
2021 -โ‚น11.48 Billion91.12%
2020 -โ‚น6.01 Billion-407.13%
2019 โ‚น1.95 B-78.63%
2018 โ‚น9.14 B117.97%
2017 โ‚น4.19 B-574.65%
2016 -โ‚น0.89 Billion-110.83%
2015 โ‚น8.16 B-4.5%
2014 โ‚น8.54 B-638.53%
2013 -โ‚น1.59 Billion-137.98%
2012 โ‚น4.17 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AbbVie
ABBV
โ‚น149.12 B-2,025.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น2.910 T-37,685.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น400.80 B-5,276.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น2.074 T-26,889.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น721.65 B-9,419.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.475 T-19,149.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland